Viewing register:

PPB

Marketing Authorisation Holder

TAKEDA PHARMA A/S

FOREIGN

5

Total Medicines

5

Active

5

Dosage Forms

1

Country

Kenya (5)

Registration Status

Registered 5

Dosage Forms

EACH CAPSULE CONTAINS 4 MG OF IXAZOMIB (AS 5.7 MG OF IXAZOMIB CITRATE) 1 EACH CAPSULE CONTAINS 3 MG OF IXAZOMIB (AS 4.3 MG OF IXAZOMIB CITRATE) 1 EACH CAPSULE CONTAINS 2.3 MG OF IXAZOMIB (AS 3.3 MG OF IXAZOMIB CITRATE) 1 50MG PER VIAL 1 300MG 1

Therapeutic Classes

NEW/INNOVATOR 5

Local Agents / Applicants

TAKEDA PHARMA A/S 5

Registered Medicines

Showing 5 of 5

Product	Form / Strength	Country	Reg. Number	Status
ADCETRIS BRENTUXIMAB VEDOTIN	50MG PER VIAL	Kenya	H2018/5518/138ER	Registered
ENTYVIO VEDOLIZUMAB	300MG	Kenya	H2022/CTD7332/14424	Registered
NINLARO 2.3 MG HARD CAPSULES IXAZOMIB CITRATE	EACH CAPSULE CONTAINS 2.3 MG OF IXAZOMIB (AS 3.3 MG OF IXAZOMIB CITRATE)	Kenya	H2021/CTD6854/13170	Registered
NINLARO 3 MG HARD CAPSULES IXAZOMIB CITRATE	EACH CAPSULE CONTAINS 3 MG OF IXAZOMIB (AS 4.3 MG OF IXAZOMIB CITRATE)	Kenya	H2021/CTD6855/13171	Registered
NINLARO 4 MG HARD CAPSULES IXAZOMIB CITRATE	EACH CAPSULE CONTAINS 4 MG OF IXAZOMIB (AS 5.7 MG OF IXAZOMIB CITRATE)	Kenya	H2021/CTD6856/13172	Registered